`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`TEVA PHARMACEUTICALS
`INTERNATIONAL GMBH and TEVA
`PHARMACEUTICALS USA, INC.,
`
`Plaintiffs,
`
` Case No. 1:18-cv-12029-ADB
`
`v.
`ELI LILLY AND COMPANY,
`
`Defendant.
`
`NOTICE OF APPEARANCE OF MARTIN C. TOPOL
`
`Please enter the appearance of Martin C. Topol of Goodwin Procter LLP as counsel of
`
`record for Plaintiffs Teva Pharmaceuticals International GMBH and Teva Pharmaceuticals USA,
`
`Inc., in the above-captioned matter.
`
`Dated: October 31, 2018
`
`Respectfully submitted,
`
`/s/ Martin C. Topol
`Martin C. Topol (BBO#696020)
`GOODWIN PROCTER LLP
`100 Northern Avenue Boston,
`MA 02210
`Tel.: (617) 570-1000
`Fax: (617) 523-1231
`MTopol@goodwinlaw.com
`
`Attorney for Plaintiffs
`
`
`
`Case 1:18-cv-12029-ADB Document 15 Filed 10/31/18 Page 2 of 2
`
`CERTIFICATE OF SERVICE
`
`I, Martin C. Topol, hereby certify that a copy of the foregoing document, filed through
`the CM/ECF system, will be sent electronically to the registered participants as identified on the
`Notice of Electronic Filing (NEF) and paper copies shall be served by first class mail postage
`prepaid on all counsel who are not served through the CM/ECF system on October 31, 2018.
`
`/s/ Martin C. Topol
`Martin C. Topol
`
`2
`
`